Latest News

Rua Bioscience Limited announced today that it has received its narcotic license through Nimbus Health GmbH for distribution and marketing of ...

Greenfern Industries has secured a lucrative export deal that could be worth more than NZD$1.6m. Read more ...

Greenfern Industries Limited is pleased to announce it has attained its globally-recognised GACP (Good Agriculture and Collection Practice) certification for its ...

Cannasouth recently completed the first commercial harvest from our hybrid, controlled environment cultivation facility. This was a major milestone for us ...

New Zealand-based biotechnology company Greenlab has joined forces with licenced producer Helius Therapeutics to develop specialised and targeted medicinal cannabis treatments ...

Greenfern Industries’ GMP medicine prescription sales in the Australian market are going from strength to strength. Read more ...

Successful assessment by the Medicinal Cannabis Agency of Cannasouth’s first medicinal cannabis products will deliver wider treatment options to New Zealand ...

Julie Curphey has been appointed Chief Commercial Officer (CCO) at Helius Therapeutics – New Zealand’s largest licenced medicinal cannabis company. Prior ...

Helius was New Zealand’s first medicinal cannabis business to achieve a GMP Licence for Manufacturing Medicines in July 2021, covering the ...

Rua is one of just two companies in New Zealand manufacturing medicinal cannabis that has met the minimum quality standards as ...

Helius Therapeutics has launched a collaboration with the University of Canterbury (UC) to test how accurately conditions such as stress ...

A partnership between the Government and Marlborough-based medicinal cannabis grower Puro will fast-track New Zealand’s organic medicinal cannabis industry. Managing director Tim ...